본문으로 건너뛰기
← 뒤로

Quality of Cancer Care in California After Full Implementation of the Affordable Care Act: Findings from a Population-Based Study.

1/5 보강
American journal of preventive medicine 2026 p. 108333
Retraction 확인
출처

Parikh-Patel A, Yang NT, Maguire FB, Hofer BM, Wun T, Keegan THM

📝 환자 설명용 한 줄

[INTRODUCTION] Although previous studies investigated the impact of the Affordable Care Act (ACA) on insurance coverage, cancer screening, and mortality, its impact on cancer care quality is understud

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • OR 0.76

이 논문을 인용하기

↓ .bib ↓ .ris
APA Parikh-Patel A, Yang NT, et al. (2026). Quality of Cancer Care in California After Full Implementation of the Affordable Care Act: Findings from a Population-Based Study.. American journal of preventive medicine, 108333. https://doi.org/10.1016/j.amepre.2026.108333
MLA Parikh-Patel A, et al.. "Quality of Cancer Care in California After Full Implementation of the Affordable Care Act: Findings from a Population-Based Study.." American journal of preventive medicine, 2026, pp. 108333.
PMID 41831700 ↗

Abstract

[INTRODUCTION] Although previous studies investigated the impact of the Affordable Care Act (ACA) on insurance coverage, cancer screening, and mortality, its impact on cancer care quality is understudied. This study examined receipt of guideline-concordant care by health insurance type after ACA implementation.

[METHODS] A cohort of 218,436 individuals aged 20-64 with cancers of the breast, colon, endometrium, stomach, lung, and ovary between 2014 and 2021 was identified in the California Cancer Registry. Guideline-concordant care was defined by Commission on Cancer quality measures. Insurance was categorized as: private, Medicaid, Medicare, other public, and uninsured. Logistic regression models assessed the associations between insurance type and receipt of guideline-concordant care, adjusting for sex, race, ethnicity, neighborhood socioeconomic status, comorbidity and reporting region. Analyses were conducted in 2025.

[RESULTS] Individuals with Medicaid or Medicare insurance had 23%-54% lower odds of having guideline-concordant radiation, chemotherapy, and surgery for breast and colon cancer compared to privately insured individuals. Individuals with Medicaid were less likely to have guideline-concordant chemotherapy for lung cancer (odds ratio (OR)=0.63, 95% confidence interval (CI) = 0.44-0.89) compared to those with private insurance. Individuals with Medicare insurance were less likely to have recommended lung cancer surgery and pathological examination compared to those who were privately insured (OR=0.76, CI=0.60-0.96).

[CONCLUSION] Substantial disparities in cancer care quality by insurance type exist in the post-ACA era in California. More research on the individual and structural factors that may explain the observed differences is needed.